Successful treatment of recurrent refractory Kaposi’s sarcoma in AIDS: a case report
Author Information
Author(s): Li Feng, Zheng Rongrong, Yan Jun, Zhang Zhongdong, Liu Hong, Shi Jinchuan
Primary Institution: The Second Infectious Disease Department, Xixi Hospital of Hangzhou, Hangzhou, China
Hypothesis
Can PD-1 inhibitors effectively treat recurrent refractory Kaposi’s sarcoma in AIDS patients?
Conclusion
The PD-1 inhibitor led to complete remission in a patient with recurrent AIDS-related Kaposi’s sarcoma.
Supporting Evidence
- The patient achieved complete remission after treatment with a PD-1 inhibitor.
- Previous chemotherapy with anthracyclines was ineffective.
- The PD-1 inhibitor was well-tolerated with few adverse effects.
Takeaway
A patient with a serious skin disease got better after taking a special medicine that helps the body's immune system fight the disease.
Methodology
The patient was treated with a PD-1 inhibitor after failing previous chemotherapy, leading to complete remission.
Limitations
This is a single case report, limiting the generalizability of the findings.
Participant Demographics
A 30-year-old male patient with AIDS.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website